Pharmaceutical composition comprising octreotide microparticles

Details for Australian Patent Application No. 2011200966 (hide)

Owner Novartis AG

Inventors Loffler, Rolf; Lambert, Olivier; Petersen, Holger; Ausborn, Michael; Bonny, JeanDaniel

Agent Davies Collison Cave

Pub. Number AU-A-2011200966

Parent 2008200018

Filing date 4 March 2011

Wipo publication date 24 March 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

24 March 2011 Application Open to Public Inspection

  Published as AU-A-2011200966

24 March 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200967-Protecting a virtual system against computer attacks

2011200965-Expression cassettes for vascular tissue-preferential expression in plants